1-methyl-1H-indazole-3-carbonitrile, 95.0%, 100mg

1-(2-Nitro-4-(trifluoromethyl)phenyl)ethan-1-one, 97%, 250mg

2-Trifluoromethylbenzylsulfonyl chloride, 97.0%, 250mg

1-Butyl-3-methylimidazolium tetrafluoroborate, 97.0%, 100g

2,8-Dibromoindeno[1,2-b]fluorene-6,12-dione, 97%, 1g

2-(3-Bromopropyl)-1,3-dioxolane, 95.0%, 10g

Di-tert-butyl (R)-2-(aminomethyl)piperazine-1,4-dicarboxylate, 97%, 1g

1,3-Dithiole-2-thione, 97%, 1g

5-Hydroxyisobenzofuran-1,3-dione, 95.0%, 250mg

Microliter syringe GASTIGHT® series 1700 Point type 2, 50 µl, 1705 RN, 1 piece

7-Chloro-4-methoxy-benzofuran, 98%, 1g

2-Chloro-4-(trifluoromethyl)phenylboronic acid, 96.0%, 5g